FIELD: medicine.
SUBSTANCE: there is disclosed analysis of protein sample containing pancreatine and/or mixed pancreatine-like digestive enzyme by two-dimensional electrophoresis in gel.
EFFECT: optimised analysis of pancreatine, first of all deposited pancreatine or mini-microsphere pancreatine samples to be used in pharmaceutics.
13 cl, 11 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2686460C2 |
| MILK FRACTIONS ENRICHED WITH ANGIOGENINE | 2009 |
|
RU2538654C2 |
| METHOD OF LYSOZYME DIMER PREPARING | 1990 |
|
RU2067617C1 |
| EXTRACELLULAR HYALURONIDASE FROM Streptomyces koganeiensis | 2010 |
|
RU2553205C2 |
| RECEPTOR OF FIBRONECTIN ED-DOMEN | 2001 |
|
RU2280254C2 |
| ENZYMES FOR PHARMACEUTICAL APPLICATION | 2005 |
|
RU2389504C2 |
| METHOD OF RECOVERING OXIDASE OF D-AMINO ACID FROM TRIGONOPSIS VARIABILIS | 0 |
|
SU1604163A3 |
| CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS UNSTABLE IN MEDICINAL ACID MEDIUM | 2006 |
|
RU2440101C2 |
| ENZYMATIC SYNTHESIS OF L-NUCLEIC ACIDS | 2013 |
|
RU2704833C2 |
| NEW FUNCTIONAL, HIGH-PURITY STABLE CONJUGATE OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AND POLYETHYLENE GLYCOL WITH PROLONGED BIOLOGICAL ACTION, APPLICABLE FOR MEDICAL PURPOSES, AND BASED IMMUNOBIOLOGICAL AGENT | 2010 |
|
RU2446173C1 |
